Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naltrexone”

392 trials

Showing 20 of 392 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07433413
What this trial is testing

Evaluate the Efficacy and Safety of Naltrexone Hydrochloride Implant in Patients With Alcohol Use Disorder

Who this might be right for
Alcohol Use Disorder (AUD)
Shenzhen Sciencare Medical Industries Co., Ltd. 240
Not applicableWithdrawnNCT05307627
What this trial is testing

The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging

Who this might be right for
Aging
AgelessRx
Post-approval studies (Phase 4)Study completedNCT00006203
What this trial is testing

Naltrexone, Craving, and Drinking

Who this might be right for
Alcoholism
Brown University 180
Large-scale testing (Phase 3)Study completedNCT02110264
What this trial is testing

Injectable Pharmacotherapy for Opioid Use Disorders (IPOD)

Who this might be right for
Opioid Use Disorders
University of California, Los Angeles 151
Testing effectiveness (Phase 2)Study completedNCT00142909
What this trial is testing

Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1

Who this might be right for
Opioid-Related Disorders
Yale University 86
Early research (Phase 1)Study completedNCT00218530
What this trial is testing

Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1

Who this might be right for
Heroin Dependence
National Institute on Drug Abuse (NIDA)
Post-approval studies (Phase 4)Study completedNCT00920829
What this trial is testing

Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism

Who this might be right for
Alcohol Dependence
Medical University of South Carolina 358
Early research (Phase 1)Study completedNCT03769064
What this trial is testing

Study for Naltrexone on the Abuse Potential of Methylphenidate

Who this might be right for
NaltrexoneMethylphenidate Abuse
Avekshan LLC 94
Large-scale testing (Phase 3)Looking for participantsNCT06633900
What this trial is testing

Naltrexone for Overdose Prevention

Who this might be right for
Overdose Accidental
University of California, San Francisco 100
Large-scale testing (Phase 3)Study completedNCT03539900
What this trial is testing

Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating Disorder

Who this might be right for
Binge-Eating Disorder
Yale University 89
Large-scale testing (Phase 3)Study completedNCT01402492
What this trial is testing

Cocaine Use Reduction With Buprenorphine

Who this might be right for
Cocaine Dependence
University of California, Los Angeles 302
Post-approval studies (Phase 4)Study completedNCT00000452
What this trial is testing

Naltrexone Treatment of Alcohol Dependence

Who this might be right for
Alcoholism
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 240
Testing effectiveness (Phase 2)Study completedNCT00015080
What this trial is testing

Naltrexone in Treatment of Cocaine Dependence - 5

Who this might be right for
Cocaine-Related Disorders
National Institute on Drug Abuse (NIDA)
Testing effectiveness (Phase 2)Looking for participantsNCT06366724
What this trial is testing

LIFT: Life Improvement Trial

Who this might be right for
ME/CFSLong COVIDPASC
Brigham and Women's Hospital 160
Large-scale testing (Phase 3)Study completedNCT00577408
What this trial is testing

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone

Who this might be right for
Opiate DependenceHeroin Dependence
New York State Psychiatric Institute 60
Early research (Phase 1)Study completedNCT01738867
What this trial is testing

To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers

Who this might be right for
Alcoholism
GlaxoSmithKline 56
Post-approval studies (Phase 4)Study completedNCT00006204
What this trial is testing

Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine)

Who this might be right for
AlcoholismAlcohol DependenceDepression
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 106
Testing effectiveness (Phase 2)Study completedNCT01449565
What this trial is testing

Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM)

Who this might be right for
Amphetamine-Related Disorders
San Francisco Department of Public Health 100
Early research (Phase 1)Study completedNCT01825447
What this trial is testing

Characterize the Abuse Liability of Intravenous Oxycodone Alone or in Combination With Intravenous Naltrexone in Healthy, Non-Dependent, Recreational Opioid Users

Who this might be right for
Healthy
Pfizer 89
Large-scale testing (Phase 3)Study completedNCT01571362
What this trial is testing

A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain

Who this might be right for
Chronic PainLow Back PainAnalgesia
Pfizer 410
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation